Trials / Completed
CompletedNCT02245958
A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 44 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a retrospective chart review to evaluate the doses of botulinum Type A toxins BOTOX® (onabotulinumtoxinA) and Xeomin® (incobotulinumtoxinA) used for the treatment of Cervical Dystonia and Blepharospasm in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No treatment (intervention) was administered. |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-09-22
- Last updated
- 2016-01-08
Locations
2 sites across 2 countries: Mexico, United Kingdom
Source: ClinicalTrials.gov record NCT02245958. Inclusion in this directory is not an endorsement.